BiondVax Pharmaceuticals Receives New Coverage from Analysts at StockNews.com
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
BiondVax |
StockNews.com started coverage on shares of BiondVax Pharmaceuticals in a research report released on Thursday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance BiondVax Pharmaceuticals stock opened at 1.35 on Thursday. The company has a market cap of 2.52 million, a PE ratio of -0.53 and
Read at thelincolnianonline.com
 |
BiondVax Pharmaceuticals Fundamental Analysis
We analyze BiondVax Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
BiondVax Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
BiondVax Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BiondVax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BiondVax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
BiondVax Pharmaceuticals Related Equities
| ADTX | Aditxt | 5.56 | ||||
| GOVX | GeoVax Labs | 4.68 | ||||
| ARMP | Armata Pharmaceuticals | 4.46 | ||||
| ANTX | AN2 Therapeutics | 4.35 | ||||
| ATXI | Avenue Therapeutics | 4.30 | ||||
| CANF | Can Fite | 3.95 | ||||
| SABS | SAB Biotherapeutics | 1.95 | ||||
| SLRX | Salarius Pharmaceuticals | 0.60 | ||||
| ORMP | Oramed Pharmaceuticals | 0.42 | ||||
| MOLN | Molecular Partners | 0.19 | ||||
| PHVS | Pharvaris | 0.36 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| MDWD | Mediwound | 0.73 | ||||
| VCNX | Vaccinex | 0.91 | ||||
| KTTA | Pasithea Therapeutics | 2.15 | ||||
| ADIL | Adial Pharmaceuticals | 2.86 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| BLRX | BioLineRx | 4.35 | ||||
| RNAZ | Transcode Therapeutics | 5.66 | ||||
| SRZN | Surrozen | 5.95 | ||||
| PEPG | PepGen | 8.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |